Donor and recipient pretransplant conditioning with nonlethal radiation and antilymphocyte serum improves the graft survival in a rat small bowel transplant model

Transplantation

Volumn 72, Issue 6, 2001, Pages 983-988

  Bakonyi, Alexandre ^a,b   Berho, Mariana ^a   Ruiz, Phillip ^a   Misiakos, Evangelos P ^a   Carreno, Manuel ^a   De Faria, Werviston ^a   Sommariva, Antonio ^a   Inverardi, Luca ^a   Miller, Joshua ^a   Ricordi, Camillo ^a   Tzakis, Andreas G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY CD3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CHIMERA; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOMODULATION; INTESTINE TRANSPLANTATION; MALE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; SERUM; T LYMPHOCYTE; WHOLE BODY RADIATION;

EID: 0035960044     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200109270-00001     Document Type: Article

References (27)

1. Intestinal and multivisceral transplantation
2. Clinical intestinal transplantation. New perspectives and immunologic considerations
3. Preliminary experience with intestinal transplantation in infants and children
4. Donor bone marrow, chimerism, histocompatibility and renal allograft rejection
5. High-dose donor bone marrow infusions to enhance allograft survival
6. Perioperatrive donor bone marrow infusion in recipients of organ allografts
7. Correlation between allograft survival and chimeric state after bone marrow infusions in rat small bowel transplantation
8. Transplantation of small bowel in the rat: Technical and immunological considerations
9. A partial conditioning strategy for achieving mixed chimerism in the rat: Tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment
10. Lymphohematopoietic engraftment in minimally myeloablated hosts
11. Determinants of engraftment after allogeneic marrow transplantation
12. Recipient preconditioning and donor-specific bone marrow infusion in a pig model of total bowel transplantation
13. Features of T cell causing H-2 restricted lethal graft-versus- host disease across minor histocompatibility barriers
14. Surface markers of T-cells causing lethal graft-versus-host disease to class I vs. class II H-2 differences
15. Induction of immune skin lesions by T lymphocyte clones of particular subclasses
16. Mixed chimerism in the rat
17. Induction of specific tolerance to small bowel allografts
18. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown Norway rats
19. Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion
20. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID): Evidence that natural killer cells mediate the specificity of marrow graft rejection
21. Abrogation of resistance to bone marrow grafts by silica particles: Prevention of silica effect by the macrophage stabilizer poly-2-vinylpyridine N-oxide
22. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance
23. Peculiar immunobiology of bone marrow allografts: I. Graft rejection by irradiated responder mice
24. Acute rejection of murine bone marrow allografts by natural killer cells and T cells: Differences in kinetics and target antigens recognized
25. Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation
26. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen
27. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach